Predictive design of crystallographic chiral separation
The efficient separation of chiral molecules is a fundamental challenge in the manufacture of pharmaceuticals and light-polarising materials. We developed an approach that combines machine learning with a physics-based representation to predict resolving agents for chiral molecules, using a transformer-based neural network. In retrospective tests, our approach reaches a four to six-fold improvement over the historical - trial and error based - hit rate. We further validate the model in a prospective experiment, where we use the model to design a resolution screen for six unseen racemates. We successfully resolved three of the six mixtures in a single round of experiments and obtained an overall 8-to-1 true positive to false negative ratio. Together with this study, we release a previously proprietary dataset of over 6000 resolution experiments, the largest diastereomeric salt crystallisation dataset to date. More broadly, our approach and open crystallisation data lay the foundation for accelerating and reducing the costs of chiral resolutions.
Authors
- Jacquelyn Klug‐McLeod
- Qingyi Yang (ORCID: https://orcid.org/0000-0001-5269-0494)
- William Farrell (ORCID: https://orcid.org/0000-0002-3341-9831)
- Louise Bernier
- Xinjun Hou (ORCID: https://orcid.org/0000-0002-3473-8455)
- Emma King‐Smith (ORCID: https://orcid.org/0000-0002-2999-0955)
- Neal W. Sach (ORCID: https://orcid.org/0000-0002-9966-7459)
- Alpha A. Lee (ORCID: https://orcid.org/0000-0002-9616-3108)
- Jason Mustakis (ORCID: https://orcid.org/0000-0002-8683-0691)
- Felix A. Faber (ORCID: https://orcid.org/0000-0002-3576-4137)
- Roger M. Howard (ORCID: https://orcid.org/0000-0001-5884-4896)
- Simon Berritt (ORCID: https://orcid.org/0000-0001-5572-6771)
- Rokas Elijošius (ORCID: https://orcid.org/0000-0001-6397-0002)
Institutions
- Pfizer (United States) (US)
- University of Cambridge (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1038/s41467-025-62825-4
- Citations
- 1
- Primary Topic
- Crystallization and Solubility Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.52
Funders
- Pfizer
- Engineering and Physical Sciences Research Council